Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Klinik und Poliklinik für Onkologie

Universitätsspital Zürich

The main field of our research is the development of innovative treatment modalities for cancer patients. By eliciting cell-mediated immune responses we aim at inducing specific immunity against tumor cells. This program consists of 3 major topics, including clinical trials activities, direct assessment of tumor reactive T lymphocytes and molecular biology/SEREX-based antigen discovery. Our institute is affiliated with the Ludwig Institute for Cancer Research (http://www.licr.org) and the Cancer Research Institute (http://www.cancerresearch.org). Both institutes have initiated an international cancer vaccine program that aims at the transition of discoveries from the laboratory in the clinic and is embedded in a collaborative academic environment. We are currently initiating clinical trials within this program. There is a close collaboration to Dr. Jäger at the Krankenhaus Nordwest, Frankfurt (http://www.krankenhaus-nordwest.de/nwk/fk_med_klinik_2.htm). Please contact our website (http://www.dim.unizh.ch/onkolog/index.htm) to get further information on these research activities.

Details


Adresse:
Klinik und Poliklinik für Onkologie
Universitätsspital Zürich
Rämistrasse 100
8091
Deutschland
Arbeitsgebiet:
Forschung & Entwicklung
Expansion:
international
Mitarbeiteranzahl:
1-10
Gründungsjahr:
2003